Magnetic Resonance Imaging and Spectroscopy of the Prostate
Observational
Observational Model: Cohort, Time Perspective: Prospective
Determine added value in combining MRSI and MRI in prostate cancer treatment
3 hours
No
Hedvig Hricak, MD
Principal Investigator
Memorial Sloan-Kettering Cancer Center
United States: Food and Drug Administration
00-136
NCT00590993
December 2000
February 2013
Name | Location |
---|---|
Memorial Sloan Kettering Cancer Center | New York, New York 10021 |